Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
about
Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research.The Impact of Residual Symptoms in Major DepressionAripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.Improving quality of depression care using organized systems of care: a review of the literature.Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.Pioglitazone could induce remission in major depression: a meta-analysisReal-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review studyStability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatientsRelationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.Standardised rating scales in psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales.Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach.Managing weight in persons living with severe mental illness in community settings: a review of strategies used in community interventions.Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.Clinical trial design in non-invasive brain stimulation psychiatric research.Management of chronic depressive patients with residual symptoms.Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response.No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy.Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank.Functional change of the auditory cortex related to brain serotonergic neurotransmission in type 1 diabetic adolescents with and without depression.Re-evaluation of the definition of remission on the 17-item Hamilton Depression Rating Scale based on recovery in health-related quality of life in an observational post-marketing study.Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient.Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: An updated meta-analysis.Self-efficacy is associated with less burden and more gains from behavioral problems of Alzheimer's disease in Hong Kong Chinese caregivers.Psychiatric diagnoses during institutionalization: an investigation of 1334 psychiatric patients hospitalized in an Italian asylum during the 20th century.Verbal working memory and functional outcome in patients with unipolar major depressive disorder.Remission in Depression and Associated Factors at Different Assessment Times in Primary Care in Chile.
P2860
Q33427001-40DC5340-C63D-4F0D-A584-7C89A20F0EB7Q33664080-59B93149-3A57-40B4-824F-89B537EDBD86Q33799660-3DD563E5-AB8F-4F4C-83B5-0F74BEA744C3Q33952577-A91BACAA-BAF6-481F-9976-85D7AB90028FQ34543946-1FC51914-97A4-4CEA-9A18-E8EFD9B09FDBQ34548227-96A8A74F-2062-48EB-926F-F36A7FEFFE33Q35666205-4E465973-0FF9-4C74-BE17-9F7747E02781Q36024493-4DAABD32-8B9D-4A48-88E7-BD06B54A1BB3Q36070303-53CFC473-CF11-40DC-A8DD-930CEFBE7812Q37229333-EA157778-4C20-4B1C-8DD2-666572620FCAQ37252495-0C2E4DF6-6A9D-45BF-AFD2-7AE7919C80FAQ37405307-FCF10D64-D828-4FB6-9A38-97AC204987EDQ37539807-5A728170-7399-498F-89B6-BDA3AB321109Q37623789-9C347E99-EDB5-4F21-9266-31DE8D73E91AQ37737291-4709B171-CA1D-447A-8F93-B3B744FEE481Q37871523-7A63744F-B85A-4D98-BF07-9E767D0580D9Q38109593-26C06F9F-6735-4E63-8862-BCCFB1FED76DQ38604950-3513B6DD-5A1C-4A25-9BED-4A662A1026D1Q40314455-EA38DD23-BABF-42FE-B2C6-E3DCA8EBAC7AQ42651772-7401AB3A-5204-4507-A2FB-3F039CCF2B9CQ43450643-6735B0E8-4EDC-45EB-A5D8-9A40A0FF22D4Q46092349-A3160956-29D1-45EB-817C-2CE2405F1259Q47555291-9D2B9D7A-8F27-467E-82EB-F3D82D091CEEQ47599068-7EEB2C91-EB85-4E20-AEB2-27FC46BADE4EQ47605999-FA756D42-2E2C-45E5-8662-E6A9F34B4F43Q47801358-2DC317C2-5833-442A-BD9C-159769C66A47Q48652744-AECCC058-F820-4B09-BE17-ABCA0CFB55F4Q51768252-666A265B-50EB-4F21-AE3A-3EF674C1FFF0Q55279690-27438C8C-A3B2-475C-B88E-5B34088DB86F
P2860
Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Outcomes in major depressive d ...... ts implications for treatment.
@en
Outcomes in major depressive d ...... ts implications for treatment.
@nl
type
label
Outcomes in major depressive d ...... ts implications for treatment.
@en
Outcomes in major depressive d ...... ts implications for treatment.
@nl
prefLabel
Outcomes in major depressive d ...... ts implications for treatment.
@en
Outcomes in major depressive d ...... ts implications for treatment.
@nl
P2860
P1476
Outcomes in major depressive d ...... ts implications for treatment.
@en
P2093
Hans-Jürgen Möller
P2860
P304
P356
10.1080/15622970801981606
P577
2008-01-01T00:00:00Z